Home / Genito-urinary system and sex hormones / Conjugated Estrogens
ATC G03CA57 · Natural and Semisynthetic Estrogens, Plain
Conjugated Estrogens shortage
As of 2 Nov 2026, Conjugated Estrogens has a reported shortage in 2 of the 16 countries we track (Canada, Ireland), covering 3 products from 1 company.
Countries2/16
Products3packs or presentations
Companies11 listed
Short since30 Jun 20264 months ago
Earliest return9 Nov 2026company estimate
Main reasonIncreased demand
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIreland2 products shortAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
CanadaIreland
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Pfizer PFE · NYSE
Compared with similar medicines
ATC group G03CA · Natural and Semisynthetic Estrogens, PlainAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PREMARIN VAGINAL CREAM (30g tube) | PFIZER CANADA ULC | 30 Jun 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| IE | Premarin 1.25 mg Prolonged-release tablets | Pfizer Healthcare Ireland Unlimited Company | 19 Oct 2026 | 9 Nov 2026 | Increased demand Unexpected increased demand |
| IE | Premarin 0.625 mg Prolonged-release tablets | Pfizer Healthcare Ireland Unlimited Company | 2 Nov 2026 | 20 Nov 2026 | Increased demand Unexpected increased demand |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.